Annual Working Capital
$365.41 M
+$216.33 M+145.11%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual working capital is $365.41 million, with the most recent change of +$216.33 million (+145.11%) on December 31, 2023.
- During the last 3 years, AXSM annual working capital has risen by +$204.82 million (+127.55%).
- AXSM annual working capital is now at all-time high.
Performance
AXSM Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$282.93 M
+$6.47 M+2.34%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly working capital is $282.93 million, with the most recent change of +$6.47 million (+2.34%) on September 30, 2024.
- Over the past year, AXSM quarterly working capital has dropped by -$82.48 million (-22.57%).
- AXSM quarterly working capital is now -30.09% below its all-time high of $404.71 million, reached on June 30, 2023.
Performance
AXSM Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AXSM Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +145.1% | -22.6% |
| 3 y3 years | +127.5% | +213.3% |
| 5 y5 years | +8217.6% | +999.7% |
AXSM Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +475.9% | -30.1% | +360.7% |
| 5 y | 5-year | at high | +475.9% | -30.1% | +360.7% |
| alltime | all time | at high | >+9999.0% | -30.1% | >+9999.0% |
Axsome Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $282.93 M(+2.3%) |
| Jun 2024 | - | $276.46 M(-12.6%) |
| Mar 2024 | - | $316.44 M(-13.4%) |
| Dec 2023 | $365.41 M(+145.1%) | $365.41 M(-8.0%) |
| Sep 2023 | - | $397.10 M(-1.9%) |
| Jun 2023 | - | $404.71 M(+98.6%) |
| Mar 2023 | - | $203.80 M(+36.7%) |
| Dec 2022 | $149.08 M(+134.9%) | $149.08 M(-22.4%) |
| Sep 2022 | - | $192.10 M(+212.8%) |
| Jun 2022 | - | $61.41 M(-1.4%) |
| Mar 2022 | - | $62.28 M(-1.8%) |
| Dec 2021 | $63.45 M(-60.5%) | $63.45 M(-29.7%) |
| Sep 2021 | - | $90.32 M(-24.0%) |
| Jun 2021 | - | $118.79 M(-17.1%) |
| Mar 2021 | - | $143.35 M(-10.7%) |
| Dec 2020 | $160.59 M(-18.0%) | $160.59 M(-12.2%) |
| Sep 2020 | - | $182.93 M(+9.0%) |
| Jun 2020 | - | $167.82 M(-2.2%) |
| Mar 2020 | - | $171.52 M(-12.4%) |
| Dec 2019 | $195.88 M | $195.88 M(+661.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $25.73 M(-38.0%) |
| Jun 2019 | - | $41.50 M(+15.1%) |
| Mar 2019 | - | $36.05 M(+720.6%) |
| Dec 2018 | $4.39 M(-81.0%) | $4.39 M(-12.2%) |
| Sep 2018 | - | $5.00 M(-58.4%) |
| Jun 2018 | - | $12.01 M(-34.5%) |
| Mar 2018 | - | $18.33 M(-20.7%) |
| Dec 2017 | $23.12 M(-25.0%) | $23.12 M(-3.7%) |
| Sep 2017 | - | $24.02 M(-21.6%) |
| Jun 2017 | - | $30.63 M(-19.1%) |
| Mar 2017 | - | $37.84 M(+22.8%) |
| Dec 2016 | $30.83 M(-33.6%) | $30.83 M(+10.0%) |
| Sep 2016 | - | $28.02 M(-19.5%) |
| Jun 2016 | - | $34.81 M(-15.4%) |
| Mar 2016 | - | $41.15 M(-11.3%) |
| Dec 2015 | $46.40 M(+2519.7%) | $46.40 M(+1598.9%) |
| Sep 2015 | - | $2.73 M(-46.8%) |
| Jun 2015 | - | $5.14 M(+190.1%) |
| Dec 2014 | $1.77 M(-187.3%) | $1.77 M |
| Dec 2013 | -$2.03 M | - |
FAQ
- What is Axsome Therapeutics annual working capital?
- What is the all time high annual working capital for Axsome Therapeutics?
- What is Axsome Therapeutics annual working capital year-on-year change?
- What is Axsome Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly working capital year-on-year change?
What is Axsome Therapeutics annual working capital?
The current annual working capital of AXSM is $365.41 M
What is the all time high annual working capital for Axsome Therapeutics?
Axsome Therapeutics all-time high annual working capital is $365.41 M
What is Axsome Therapeutics annual working capital year-on-year change?
Over the past year, AXSM annual working capital has changed by +$216.33 M (+145.11%)
What is Axsome Therapeutics quarterly working capital?
The current quarterly working capital of AXSM is $282.93 M
What is the all time high quarterly working capital for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly working capital is $404.71 M
What is Axsome Therapeutics quarterly working capital year-on-year change?
Over the past year, AXSM quarterly working capital has changed by -$82.48 M (-22.57%)